The Vox Markets Podcast

2445: Poolbeg’s Big Biotech Moment? First Patient Dosed Ahead of Key POLB 001 Data

Watch on YouTubePoolbeg Pharma has dosed the first patient in its POLB 001 TOPICAL clinical trial, marking the start of a key execution phase for its CRS prevention programme. With UCLH activated, further sites expected, interim data targeted for summer 2026 and partnering discussions ongoing, investors will be watching whether clinical progress can validate the programme’s claimed commercial potential.

2444: European Green Transition: Potential £126m Repowering Revenue Opportunity

Watch on YouTubeEuropean Green Transition has released a second quarter update from its Wind Energy Services business, highlighting significant growth and growth potential in its repowering and operations and maintenance businesses. The overall potential pipeline in repowering could amount to as much as £126 million in revenue. Meanwhile the broader economic backdrop, in which governments continue to seek energy security via home-grown green energy projects, continues to be favourable. Dave Broadbank, the managing director of the Wind Energy Services business, joins Vox to tell us more.

2443: 2 P's on a Pod: What Happens Next for UK Small Caps?

Watch on YouTubeIn this week’s live smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 22 stock ideas.In this week’s live smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 22 stock ideas.01:10 easyjet04:55 Jet208:10 Aim vs Main market listing10:05 Avingtrans14:30 Keller16:40 UK housebuilders: Vistry, MJ Gleeson, Crest Nicholson and Henry Boot25:10 Capita30:55 Boku and Bango37:15 Victrex43:30 Johnson Service Group46:05 Tristel51:10 Playtech54:45 Hostelworld57:50 Hays62:15 Victoria66:45 Next 1570:20 Renishaw72:55 Water Intelligence77:55 MedPal AI#EZJ #JET2 #AVG #KLR #VTY #GLE #CRST #BOOT #CPI #BOKU#BGO #TSTL #VCT #HAS #PTEC #HSW #RSW #VCP #NFG #JSG #WATR #MPAL

2442: Q&A with Verici DX CEO Sara Barrington

In this upbeat interview, CEO Sara Barrington of Verici DX – a next generation medical diagnostics firm focusing on the global kidney transplant market - takes me through last week’s ‘in line’ FY’25 results and positive outlook.Disclosure: Verici is a Vox Markets client

2441: More tungsten assay results from Great Western's Defender-Pine Crow

Great Western Mining Corp PLC: More tungsten assay results from Defender-Pine Crow Great Western Mining has released the results of a machine-cut channel sampling programme undertaken at its Defender-Pine Crow tungsten project in Nevada. The company cut four channels, and each showed tungsten mineralisation comparable to other projects in the area, notably that of Guardian Metals at Pilot Mountain. More channel samples will now likely be taken as the company moves towards a drilling campaign set to get underway in the next few weeks. Meanwhile, behind the scenes, metallurgical work is also ongoing. Great Western chief executive Ed Loye joins Vox to tell us more. ▶️ Watch the full interview: https://www.youtube.com/watch?v=ReXLQQUTm5w